LGVN – longeveron inc. - class a common stock (US:NASDAQ)
Stock Stats
News
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease [Yahoo! Finance]
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
Longeveron® to Present at the 37th Annual Roth Conference
Longeveron Inc. (NASDAQ: LGVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Analysts Expect Breakeven For Longeveron Inc. (NASDAQ:LGVN) Before Long [Yahoo! Finance]
Form 4 Longeveron Inc. For: Mar 04 Filed by: Hare Joshua
Form 8-K Longeveron Inc. For: Dec 31
Form 10-K Longeveron Inc. For: Dec 31
Form 8-K Longeveron Inc. For: Jan 27
Form 4 Longeveron Inc. For: Jan 02 Filed by: Agafonova Nataliya
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.